Abstract:Background: Chronic use of mu-opioid receptor agonists paradoxically causes both hyperalgesia and the loss of analgesic efficacy. Opioid treatment increases presynaptic N-methyl-d-aspartate receptor activity to potentiate nociceptive input to spinal dorsal horn neurons. However, the mechanism responsible for this opioid- induced activation of presynaptic N-methyl-d-aspartate receptors remains unclear. alpha 2 delta-1, formerly known as a calcium channel subunit, interacts with N-methyl-d-aspartate receptors and is primarily expressed at presynaptic terminals. This study tested the hypothesis that alpha 2 delta-1-bound N-methyl-d-aspartate receptors contribute to presynaptic N-methyl-d-aspartate receptor hyperactivity associated with opioid-induced hyperalgesia and analgesic tolerance. Methods: Rats (5 mg/kg) and wild-type and alpha 2 delta-1-knockout mice (10 mg/kg) were treated intraperitoneally with morphine twice/day for 8 consecutive days, and nociceptive thresholds were examined. Presynaptic N-methyl-d-aspartate receptor activity was recorded in spinal cord slices. Coimmunoprecipitation was performed to examine protein-protein interactions. Results: Chronic morphine treatment in rats increased alpha 2 delta-1 protein amounts in the dorsal root ganglion and spinal cord. Chronic morphine exposure also increased the physical interaction between alpha 2 delta-1 and N-methyl-d-aspartate receptors by 1.5 +/- 0.3 fold (means +/- SD, P = 0.009, n = 6) and the prevalence of alpha 2 delta-1-bound N-methyl-d-aspartate receptors at spinal cord synapses. Inhibiting alpha 2 delta-1 with gabapentin or genetic knockout of alpha 2 delta-1 abolished the increase in presynaptic N-methyl-d-aspartate receptor activity in the spinal dorsal horn induced by morphine treatment. Furthermore, uncoupling the alpha 2 delta-1-Nmethyl- d-aspartate receptor interaction with an alpha 2 delta-1 C terminus-interfering peptide fully reversed morphine-induced tonic activation of N-methyl-d-aspartate receptors at the central terminal of primary afferents. Finally, intraperitoneal injection of gabapentin or intrathecal injection of an alpha 2 delta-1 C terminus-interfering peptide or alpha 2 delta-1 genetic knockout abolished the mechanical and thermal hyperalgesia induced by chronic morphine exposure and largely preserved morphine's analgesic effect during 8 days of morphine treatment. Conclusions: alpha 2 delta-1-Bound N-methyl-d-aspartate receptors contribute to opioid-induced hyperalgesia and tolerance by augmenting presynaptic N-methyl-d-aspartate receptor expression and activity at the spinal cord level.

Β-Arrestin and Morphine Tolerance

Enhancement of Morphine Analgesia and Prevention of Morphine Tolerance by Downregulation of Β-Arrestin 2 with Antigene RNAs in Mice.

Differential regulation of β-arrestin 1 and β-arrestin 2 gene expression in rat brain by morphine

miR-365 targets β-arrestin 2 to reverse morphine tolerance in rats

Opioid tolerance: is there a dialogue between glutamate and beta-arrestin?

Improvement of Morphine-Mediated Analgesia by Inhibition of Β-Arrestin 2 Expression in Mice Periaqueductal Gray Matter

Opioid Receptor and Morphine Tolerance to Morphine Analgesia

REGULATION OF OPIOID RECEPTOR SIGNAL TRANSDUCTION VIA BETA-ARRESTINS

Role of P2X7 Receptor-Mediated IL-18/IL-18R Signaling in Morphine Tolerance: Multiple Glial-Neuronal Dialogues in the Rat Spinal Cord.

Blockade of Neuronal Dopamine D2 Receptor Attenuates Morphine Tolerance in Mice Spinal Cord

Inhibition of Morphine Tolerance by MrgC Receptor Via Modulation of Interleukin-1Β and Matrix Metalloproteinase 9 in Dorsal Root Ganglia in Rats.

Src Kinase Inhibition Attenuates Morphine Tolerance without Affecting Reinforcement or Psychomotor Stimulation

The Role of P2X Receptors in Morphine Tolerance

Α2δ-1–Boundn-methyl-d-aspartate Receptors Mediate Morphine-induced Hyperalgesia and Analgesic Tolerance by Potentiating Glutamatergic Input in Rodents

Endoplasmic Reticulum Stress in Spinal Cord Contributes to the Development of Morphine Tolerance

Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray.

Involvement Of Spinal Microglial P2x(7) Receptor In Generation Of Tolerance To Morphine Analgesia In Rats

Suppressing High Mobility Group Box-1 Release Alleviates Morphine Tolerance Via the Adenosine 5'-Monophosphate-activated Protein Kinase/heme Oxygenase-1 Pathway.

Receptor Trafficking Induced by Mu-Opioid-Receptor Phosphorylation

Potential Role of CXCL10/CXCR3 Signaling in the Development of Morphine Tolerance in Periaqueductal Gray

Decreased morphine analgesia in rat overexpressing β-arrestin 2 at periaqueductal gray